Annandale, VA; February 22, 2022
COVID-19 Vaccine Clinical Trial Update
The leaders of the Clinical Alliance for Research and Education-Infectious Diseases (CARE-ID) continue to express their extreme gratitude to its volunteer participants in the Pfizer COVID-19 vaccine and booster clinical trials. The delivery of these vaccines has substantially reduced new infections and created a pathway back to more normal lives.
“To ensure our study participants and their loved ones have the best information possible that CARE-ID can provide, we base all that we do on the science, vaccine experts, and FDA guidance and approvals, in addition to the appropriate CDC recommendations”, stated Executive Director, Steve Poretz. “Guided by these principles, we provide our Pfizer vaccine clinical trial participants updated information on the status of our on-going trials as well as information on new trials that Pfizer is considering. What we can share today is an update on an upcoming booster trial and a source for vaccine trial participants to explore and to discover additional valuable information and resources that may be useful.”